Diclofenac sodium is used to reduce pain, swelling, and inflammation from conditions like arthritis, menstrual cramps, and injuries. It works by blocking pain signals and reducing inflammation in the body.[2] Voltaren is currently approved and in use across 13 indications[4].[1]
Voltaren is one of 218 small molecule programs targeting Osteoarthritis, Hand. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
744 competitors in Breast Cancer
Voltaren
Adenocard
Lexiscan
Voltaren
Zolymbus
Blenoxane
Methylthioninium Chloride
MS Contin
Duragesic-100
MS Contin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jul 28, 1988
VOLTAREN
NDA NDA019201
Mar 28, 1991
VOLTAREN
NDA NDA020037
Nov 24, 1993
CATAFLAM
NDA NDA020142
Mar 8, 1996
VOLTAREN-XR
NDA NDA020254
May 4, 1998
DICLOFENAC SODIUM
NDA NDA020809
Oct 16, 2000
SOLARAZE
NDA NDA021005
Oct 17, 2007
VOLTAREN ARTHRITIS PAIN
NDA NDA022122
Jun 16, 2009
ZIPSOR
NDA NDA022202
Jun 17, 2009
CAMBIA
NDA NDA022165
Nov 4, 2009
PENNSAID
NDA NDA020947
Oct 18, 2013
ZORVOLEX
NDA NDA204592
Jan 16, 2014
PENNSAID
NDA NDA204623
Dec 23, 2014
DYLOJECT
NDA NDA022396
Sources